SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-035047
Filing Date
2024-02-14
Accepted
2024-02-14 07:21:55
Documents
1
Group Members
FORBION III MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d785499dsc13ga.htm SC 13G/A 51046
  Complete submission text file 0001193125-24-035047.txt   52731
Mailing Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC
Business Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC 31 35 6993000
Forbion Capital Fund III Cooperatief U.A. (Filed by) CIK: 0001747586 (see all company filings)

IRS No.: 981264117 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13G/A | Act: 34 | File No.: 005-94211 | Film No.: 24632268
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)